Pulmonary alveolar microlithiasis: an interesting case report with systematic review of Indian literature

Nidhya Ganesan , Marie Moses Ambroise , Anita Ramdas , King Herald Kisku , Kulwant Singh , Renu G’ Boy Varghese

Front. Med. ›› 2015, Vol. 9 ›› Issue (2) : 229 -238.

PDF (539KB)
Front. Med. ›› 2015, Vol. 9 ›› Issue (2) : 229 -238. DOI: 10.1007/s11684-015-0394-y
RESEARCH ARTICLE
RESEARCH ARTICLE

Pulmonary alveolar microlithiasis: an interesting case report with systematic review of Indian literature

Author information +
History +
PDF (539KB)

Abstract

Pulmonary alveolar microlithiasis is a rare disease characterized by intra-alveolar presence of microliths. This study reports an interesting case of pulmonary alveolar microlithiasis and provides a systematic review of cases reported from India. A 23-year-old female presented with a history of cough, wheeze, chest pain, and episodic wheeze for five months. Pulmonary function tests demonstrated an obstructive pattern, and chest X-ray showed fine micronodular opacities predominantly involving the middle and lower zones of both lungs. Transbronchial lung biopsy revealed the diagnosis. She responded well to inhaled steroid therapy. A systematic review of literature was performed and identified 73 cases of pulmonary alveolar microlithiasis reported from India. The mean (SD) age of the patients was 28.8 (14.9) years, with an almost equal male:female ratio. Many patients were asymptomatic at presentation. Breathlessness and cough were the most common symptoms, and the disease progressed into respiratory failure associated with cor pulmonale. About one-third of the cases were initially misdiagnosed and treated as pulmonary tuberculosis. Extra-pulmonary manifestations and co-morbidities were also evident in our series. This systematic review helps to determine epidemiological and clinical characteristics of pulmonary alveolar microlithiasis. Further research is needed to elucidate the etiopathogenesis, diagnosis, and therapeutic options, which are beneficial in developing and identifying cost-effective treatment for pulmonary alveolar microlithiasis.

Keywords

pulmonary alveolar microlithiasis / alveolar microlithiasis / microliths / rare diseases

Cite this article

Download citation ▾
Nidhya Ganesan, Marie Moses Ambroise, Anita Ramdas, King Herald Kisku, Kulwant Singh, Renu G’ Boy Varghese. Pulmonary alveolar microlithiasis: an interesting case report with systematic review of Indian literature. Front. Med., 2015, 9(2): 229-238 DOI:10.1007/s11684-015-0394-y

登录浏览全文

4963

注册一个新账户 忘记密码

1 Introduction

Pulmonary alveolar microlithiasis (PAM) is a rare disease characterized by intra-alveolar presence of microliths. It is an autosomal recessive disorder and runs in families. PAM occurs because of mutation in the sodium co-transporter (SLC34A2) gene [1]. Affected patients may range from early childhood to elderly and are usually asymptomatic during the early phase of the disease. This disease has a long and progressive course with deterioration of lung function [2].

Malphighi from Italy (1686) was the first to describe the macroscopic features of the disease, and Puhr from Hungary is credited for naming the disease in 1933 [2]. The first PAM case in India was reported by Viswanathan in 1961 [3]. This disease is extremely rare; hence, a systematic review of published cases is helpful in understanding its epidemiology, etiopathogenesis, clinical features, and diagnosis. Two interesting national reviews have already been published from Turkey and Italy [4,5]. In this study, we present an interesting case of PAM and review the literature of 52 case reports (73 cases) from India [3,656]. Majority of the case reports have been published in our national journals.

2 Our case report

A 23-year-old female, born of second-degree consanguineous marriage, presented with cough with expectoration, chest pain, and episodic wheeze for five months. The chest pain was associated with coughing. Sputum production was minimal and not foul smelling or blood tinged. No history of fever, hemoptysis, or loss of weight was present. She did not have any past history of pulmonary tuberculosis, and her personal history was unremarkable. She was not a smoker and had no history of exposure to toxic gases and fumes. Pedal edema, cyanosis, and clubbing were not present. On lung auscultation, vesicular breath sounds were heard bilaterally. Oxygen saturation was 96% on room air. Pulmonary function test revealed an obstructive pattern, with a forced vital capacity of 2.83 L (109% of predicted value), a forced expiratory volume in 1 s of 1.86 L (83% of predicted value), a FEV1/FVC ratio of 65.7 (78% of predicted value), and a PEF of 2.87 L/s (46% of predicted value).

Routine blood investigations were within normal limits, except for a mild eosinophilia. Chest X-ray showed diffuse fine micronodular opacities, predominantly involving the middle and lower zones of both lungs with relative sparing of the apices (Fig. 1). Miliary tuberculosis was initially suspected, but sputum smear and culture were negative for acid-fast bacilli. High resolution computed tomography (HRCT) of chest showed diffuse bilateral micronodules of 1–2 mm size, involving all segments of the lung (Fig. 2).

On bronchoscopy, the respiratory mucosa showed mild congestion without any significant abnormality. BAL was performed, and biopsy specimens were obtained by transbronchial lung biopsy (TBLB) from the right middle lobe. BAL did not reveal respiratory pathogens or any specific pathology. TBLB exhibited dilated alveolar spaces with laminated calcific concretions (Figs. 3 and 4). The calcospherites positively stained with von Kossa stain. Our final diagnosis was pulmonary alveolar microlithiasis with associated bronchial asthma.

We also assessed the sibling (elder brother) of our patient. He was in good health, and his chest X-ray was unremarkable. The patient was started on inhaled fluticasone propionate/formoterol combination therapy. She improved symptomatically and came regularly for follow-up visits for nine months. A repeat radiograph was performed eight months after her initial presentation, and significant change was not observed (Fig.5). Unfortunately, she was lost to follow-up thereafter.

3 Methods

3.1 Search strategy

A PubMed search was performed with the terms “pulmonary alveolar microlithiasis” OR “alveolar microlithiasis” OR “microlithiasis alveolaris pulmonale” AND “India.” The search was limited to articles published in the English language. Additional publications were also identified from the reference list of the published articles. The websites of national journals of India, such as Lung India and Indian Journal of Pathology and Microbiology were also searched to identify further citations. Cases published as a case report and subsequently in a case series or as an “interesting image” were not counted separately.

3.1.1 Inclusion criteria

We included only case reports and short case series from India published between 1961 and 2013. All cases diagnosed as PAM from India based on radiological investigations or biopsy were included in our study.

3.1.2 Exclusion criteria

Review studies were excluded. Cases without complete clinical and diagnostic details were also excluded.

Two authors independently screened the title and abstracts of the reports identified in the search. Full text articles were retrieved for relevant citations. The final list of articles was selected by consensus.

3.2 Data collection and statistical analysis

Clinical data and basic demographic details of individual cases were extracted and compiled using Microsoft Excel 2010. Categorical data and continuous variables were expressed as percentages and as mean and standard deviation, respectively.

4 Results

Our analysis included 73 PAM cases (52 case reports/short case series) reported from India between 1961 and 2013 [3,656]. The details of familial screening were available in 38 patients. A familial preponderance was evident in 21 cases. All the familial cases were siblings, except for a familial occurrence in a mother and her two daughters. The proband (mother) was married to her maternal uncle who was not affected by the disease.

A total of 37 females and 36 males with a mean±SD age of 28.8±14.9 years (median age 27.0 years; range 4–60 years) were found. Maximum cases were reported in the age group of 21–30 years (Table 1). The cases were reported from all geographic locations of India. Although occupational history was not mentioned in all the cases, the majority were housewives, students, and farmers. Three cases had history of exposure to respiratory irritants, but the occupational exposure was probably not associated with the development of PAM. A 43-year-old male had worked for four years in a cement retail shop, 15 years before developing PAM [3]. A 25-year-old housewife was employed part time in making biris (local hand-rolled cigarettes) [45]. Both the cases were familial, and their siblings were not exposed to these occupational hazards. Similarly, radiological evidence of the disease was not observed in the coworkers of a 26-year-old machine operator employed in a Calico printing factory [13].

4.1 Clinical features

Table 1 shows the frequency of common clinical signs and symptoms in various age groups. Twenty-two cases (30%) were misdiagnosed as pulmonary tuberculosis based on radiological features and started on ATT, but only one of them was sputum positive. This particular case was treated for pulmonary tuberculosis twice; the first treatment was based on sputum positivity for acid-fast bacilli, and the second treatment was based on radiological abnormalities. The patients did not improve symptomatically on ATT, and further investigations, such as lung biopsy, revealed PAM. Interestingly, only one case had developed superadded sputum positive pulmonary tuberculosis almost after 12 years of diagnosis.

Six patients aged between 24 and 60 years (mean age of 39.6±14.2 years) had died; five of them died within a week of admission, and one patient died within three months of admission. These patients had symptom duration that ranged from 3 months to 10 years. The 24-year-old patient developed pneumothorax following a bout of coughing and died of respiratory failure. Others died because of respiratory insufficiency associated with cor pulmonale. The 60-year-old female had worsening symptoms for five years and was treated at several centers with antibiotics and anti-tubercular drugs. The patient was finally diagnosed as PAM in a tertiary care center; unfortunately, she died within a week of admission. Two other patients, aged 50 years and 30 years, also had symptoms for 7 and 10 years, respectively; nevertheless, the diagnosis was established only before their death.

Long-term follow-up details were not available for majority of the patients in our series.

4.2 Imaging

Chest radiograph was performed in all patients except for one case. The characteristic finding in most of the cases were sand-like calcific micronodules (sandstorm pattern) diffusely involving both middle and lower lobes bilaterally with relative sparing of the apices. The calcific densities were confluent and denser at the bases. Other common roentgen findings included a dark radiolucent strip between the ribs, the markedly radiopaque lung parenchyma (black pleural line or negative pleural sign), and obscuration of the cardiac outline, diaphragm, and hilar vessels (the “drowned heart syndrome”). Twenty-five patients (34%) were evaluated using CT scan/high resolution CT scan. However, about 57% of the cases diagnosed after 1990 were evaluated using CT scan. Technetium-99m bone scan performed in nine patients showed diffuse increase in radiotracer uptake in both lungs.

PAM was associated with nephrolithiasis (one case), appendicitis (one case), and cholelithiasis (two cases). PAM was also associated with infertility (three males and two females).

Pulmonary function tests were performed in 40 patients. Restrictive pattern was evident in 34 patients (85.0%), and obstructive pattern and normal study in one patient (2.5%) and five patients (12.5%) were observed, respectively. Bronchoalveolar lavage was performed in nine patients and revealed the characteristic calcospherites in three cases. Lung biopsy proved to be confirmatory in 37 patients. CT-guided FNAC revealed the characteristic laminated microliths in a patient [26]. Necropsy was carried out in only one case [6].

Majority of the cases were treated conservatively, and none of the cases underwent lung transplantation. The cases in our series were predominantly reported from reputed tertiary care centers and probably represent the tip of the iceberg. A number of PAM cases are possibly undetected and even worse misdiagnosed as miliary tuberculosis in India.

5 Discussion

PAM has been reported worldwide and has no specific geographic or racial distribution. It is widely prevalent in Turkey, Italy, Japan, India, and USA. Recently, PAM is also being reported frequently from other Asian countries, such as China. PAM has no obvious sex predilection. Although PAM affects all ages, it has been most frequently discovered from birth up to 40 years old [2]. The youngest reported cases were premature twins, who died soon after birth [57]. PAM occurs in families, as well as sporadically [2,4,5,58]. Familial cases account for about half of the reported cases [4]. PAM usually affects siblings and less frequently cousins in a horizontal pattern. Parents and children are rarely affected in a vertical pattern [2]. PAM is a recessively inherited disease with complete penetrance, and no role for non-genetic mechanisms seems to exist [59,60]. Familial PAM is common in our series, and all the familial cases were siblings, except for a rare involvement of a mother and her two daughters [11]. Although the male:female ratio was equal in our series, a female predominance was noted in our familial cases (1:2 ratio). History of significant exposure to specific environmental or occupational risk factors was not observed in almost all our cases.

Recent studies have shown that PAM resulted from the mutation of the SLC34A2 gene, a type IIb sodium phosphate co-transporter gene involved in phosphate homeostasis in several organs. SLC34A2 is expressed in the apical membrane of type II alveolar cells in the lungs. These cells synthesize surfactants using phospholipids and are also involved in recycling and degrading the outdated surfactant, thereby releasing phosphates in the process. The clearance of phosphate from the alveolar space is possibly reduced because of SLC34A2 dysfunction, hence leading to the formation of microliths [1,60]. Dogan et al. analyzed three siblings with PAM in an inbred family. The genetic analysis revealed homozygous mutation in the SLC34A2 gene in all three siblings diagnosed with PAM. Both their parents (consanguineous marriage) were carriers, with heterozygous mutation of SLC34A2 gene. Thus, the impaired activity of the SLC34A2 gene may be responsible for familial PAM [61].

Autopsy studies revealed that the lungs in PAM are very hard, heavy, and incompressible. The outer surfaces of the lung appear irregular and granular because of microlith protrusion under the visceral pleura. The lungs are gritty on sectioning, and the cut surface has a sandpaper texture. The sandy microliths can be squeezed out [6,6264]. Bullous emphysematous areas can be found in the anterior margin and at the apex of the lungs [64]. Moreover, the microliths were also found within the bronchial walls in an autopsy case study [65]. Histologically, concentrically laminated calcospherites are observed within dilated alveolar spaces. The pulmonary interstitium shows varying degrees of fibrosis. Recently, morphometric analysis of CD34 immunostained sections in an autopsy case demonstrated a significant reduction in the pulmonary capillary beds, which probably leads to pulmonary hypertension [62]. Chemically, the calcospherites are composed of calcium and phosphorus salts. Traces of potassium, iron, copper, and magnesium can also be found [66].

5.1 Clinical course

PAM occurs in different age groups, but is frequently diagnosed in the second and third decades. Microliths are probably formed early in childhood, but the manifestations occur much later. The youngest patient in our series was four years old. Many patients were asymptomatic at presentation and were diagnosed incidentally. Breathlessness and cough are the most common symptoms (Tables 1 and 2). Cough probably results from the direct stimulation of the C fibers or other receptors through the microliths [58]. Clubbing is also detected frequently, and wheeze and chest pain are present in less than 10% of our cases. The disease worsens over time and usually progresses into respiratory failure associated with cor pulmonale. Death can also occur because of tension pneumothorax. In our series, the mean age at death is 39.6 years. Mascie-Taylor estimated the mean age at death to be 41.7 years [67]. Mean age at death is not mentioned in the Turkish and Italian series [4,5].

About one-third of the cases from India were misdiagnosed and treated for pulmonary tuberculosis. PAM was also misdiagnosed as miliary tuberculosis in 29% of the Italian cases [5].

5.2 Extra pulmonary manifestations

PAM can also be presented with extra-pulmonary manifestations and co-morbidities. Approximately 8% of males in our series were infertile. Semen analysis showed azoospermia in a 40-year-old male [36]. A detailed work up of infertility in a 27-year-old male revealed calcific deposit in the seminal vesicles [28]. Epididymal and periurethral calcifications causing azoospermia and punctate calcification in the seminal vesicles are associated with PAM [68,69]. Calcification of the sympathetic nervous system and possible involvement of the testes in a case of PAM is also reported [70]. Moreover, mutations in SLC34A2 are possibly associated with testicular microlithiasis [60]. These observations make an interesting aspect of PAM, which requires further research.

Co-morbidities, such as mitral stenosis [71], autosomal recessive Waardenburg anophthalmia syndrome [72], lymphocytic interstitial pneumonitis [73], milk-alkali syndrome [74], and diaphyseal aclasia [75], are rarely reported. A case of PAM with concomitant valve calcification, cholelithiasis, and idiopathic medullary nephrocalcinosis is also reported [76]. PAM is rarely associated with pulmonary tuberculosis.

5.3 Investigations

Chest X-ray, CT, and high-resolution CT findings are often diagnostic of PAM. Chest radiographs reveal diffuse areas of micronodular calcifications involving both lungs symmetrically. Tomographic evaluation confirms chest X-ray features. Minimal structural changes of the lung parenchyma can also be detected using high resolution CT scans. Most commonly, the CT scan reveals diffuse ground-glass opacities, which are associated with confluent and diffuse calcified nodules [63,77]. Ground-glass attenuation occurs because of small calculi in the alveoli. The calcifications can be observed along the bronchovascular bundles and interlobular septae. The diffuse ground glass attenuation and septal thickening with calcified nodules is referred to as the “crazy-paving” pattern in HRCT scans [77]. Meanwhile, the occurrence of calcification along the interlobular septa is attributed to the accumulation of calcospherites within the peripheral lobular parenchyma adjacent to the septa. HRCT scans can also reveal small sub-pleural cysts and linear sub-pleural calcifications. The small thin-walled sub-pleural cysts form a peripheral translucent band between the calcified lung parenchyma and the ribs, probably explaining the black pleural sign observed in chest radiographs [7779]. These small sub-pleural cysts represent dilated alveolar ducts histologically [80]. Apical bullae can also be detected by chest X-ray or CT scans. Multiple calcified pleural plaques [49] and extensive interstitial fibrosis with traction bronchiectasis are observed rarely in our series [45].

The micronodular pattern observed in PAM can mimic diseases, such as miliary tuberculosis. However, PAM involves the middle and lower lobes with relative sparing of the apices, in contrast to pulmonary tuberculosis. The characteristic dissociation between the extensive radiographic alterations and minimal symptoms also helps in diagnosing PAM. Biopsy may be needed to confirm the disease, specifically in regions with a high incidence of pulmonary tuberculosis. In the youngest patient in our series aged four, the lesions were exudative in nature during the earliest phase of the disease [13]. The exudative nodules later got calcified. Discerning these exudative lesions from miliary tuberculosis in young children who presented at an early phase of the disease can be difficult. Small calcifications in children can be difficult to detect on a chest X-ray [73].

Pulmonary function tests usually demonstrate a restrictive pattern, although patients may have a normal lung function initially. An obstructive pattern is rarely observed (Table 2). Our case showed an obstructive pattern probably due to associated bronchial asthma. Brown et al. demonstrated that the vital capacity level correctly predicts the development of pulmonary hypertension with exercise in PAM. This relationship suggests the presence of a restricted pulmonary vascular bed [81], as demonstrated recently by morphometric analysis [62].

BAL has proved to be a useful tool in the diagnosis of PAM. In our series, BAL revealed the diagnosis in 3/9 cases and in 4/6 cases in the Turkish series. Occasional cases have been diagnosed by sputum examination [36].

5.4 Treatment

Many authors emphasize that lung transplantation is the only effective treatment for PAM. Cases from India have generally been treated supportively. However, our case showed a good clinical response to steroid therapy. The role of steroids or other drugs in the management of PAM is not clear. Literature review clearly reveals that steroid cannot cure PAM. Several cases from India were treated with steroids before the diagnosis, but did not show any improvement. By contrast, a few authors have reported clinical improvement with steroids. A 56-year-old male in our series showed minimal improvement in the follow-up chest X-ray following steroid therapy [55]. Another patient initially showed some improvement of dyspnea and cyanosis, but later deteriorated [7].

A 10-year-old girl who presented with associated lymphocytic interstitial pneumonitis showed a rapid improvement in pulmonary function and exercise tolerance in response to steroid therapy [73]. Improvement was also evident in an eight-month-old infant treated with corticosteroid and hydroxychloroquine [82]. A 45-year-old woman who developed PAM after a varicella zoster virus infection with concomitant antiphospholipid syndrome and discoid lupus erythematosus responded to inhaled steroids (200 µg of budesonide per day) [83]. Pulmonary function tests revealed an obstructive pattern in our patient. Bronchial asthma has probably resulted from the chronic irritation caused by the microliths. PAM can also involve the central airways in addition to the alveoli as previously mentioned. Thus, literature review shows that only few patients have benefited from steroid therapy. Steroids cannot cure PAM, but they have provided symptomatic relief in some cases. Moreover, steroid therapy is unlikely to be effective in the late stages. Further research is needed to identify patients who are likely to benefit from steroids.

Few authors have also described the utility of disodiumetidronate, a bisphosphonate inhibiting the precipitation of hydroxyapatite microcrystals. Ozcelik et al. [84] reported clinical and radiological improvement of two patients with PAM who were treated with disodium etidronate for 9 and 11 years, respectively. The patients receiving this drug have to be closely monitored for possible side effects, such as rickets, bone fractures, and hyperphosphatemia. The drug was not effective in an earlier case treated for 18 months [85]. The effectiveness of disodium etidronate for patients who present in the late phase of the disease should be evaluated.

Lung transplantation is the only effective treatment for end-stage pulmonary disease and can be performed safely even in elderly patients. Shigemura et al. [86] reported a case of successful double lung transplantation in a 63-year-old recipient with end-stage PAM. Recently, a 64-year-old woman underwent a right-lung transplant and is able to lead an active life without any complications over a 5-year follow-up period [87]. Although complications related to transplantation have occurred in some cases, recurrence has not been reported to date [8689].

5.5 Recent advances

Recent studies, specifically from Turkey, China, and Japan, have helped us better elucidate the genetic basis of PAM [1,60,61,90]. The mutation of SLC34A2 gene is responsible for PAM, as discussed earlier. Eleven different homozygous mutations of SLC34A2 gene involving exons 1, 2, 3, 4, 6, 7, 8, 11, 12, and 13 have been identified. The predominant result of these mutations was protein truncation [90]. Interestingly, mutations seem to vary among races. Mutations in Chinese and Japanese are more likely to affect exons 7 and 8 [90]. Yin et al. [90] suggested that exon 8 may be the screen target for Chinese patients. No disease-causing mutations or single nucleotide polymorphisms in the SLC34A2 gene have also been reported [90,91]. Genes other than the SLC34A2 gene could possibly be involved in the pathogenesis of PAM. Advanced molecular research tools, such as genome-wide single nucleotide polymorphism analysis, will certainly help us gain better insights and devise novel therapeutic strategies.

Takahashi et al. [92] showed that surfactant protein-A and surfactant protein-D are potential serum markers to monitor the disease activity and progression of PAM. Dysfunction of SLC34A2 gene reduces the clearance of phosphate, hence leading to the formation of microliths. Thus, drugs targeting phosphate metabolism rather than calcium metabolism could prove to be beneficial [1].

6 Conclusions

Physicians should have a high degree of suspicion for this rare disorder in regions with a high incidence of pulmonary tuberculosis. Siblings of a patient with PAM should be screened for PAM even if they are asymptomatic. The clinical manifestations vary with the disease stage. PAM has a prolonged course and can be associated with extra pulmonary manifestations. Long-term follow-up and genetic analysis will help us to better understand the etiopathogenesis. Cost-effective treatment should also be established for PAM in developing nations.

Compliance with ethics guidelines

Nidhya Ganesan, Marie Moses Ambroise, Anita Ramdas, King Herald Kisku, Kulwant Singh, and Renu G’ Boy Varghese have no conflicts of interest to declare. This manuscript is a systematic review article and does not involve a research protocol requiring ethics committee approval.

References

[1]

Huqun , Izumi S, Miyazawa H, Ishii K, Uchiyama B, Ishida T, Tanaka S, Tazawa R, Fukuyama S, Tanaka T, Nagai Y, Yokote A, Takahashi H, Fukushima T, Kobayashi K, Chiba H, Nagata M, Sakamoto S, Nakata K, Takebayashi Y, Shimizu Y, Kaneko K, Shimizu M, Kanazawa M, Abe S, Inoue Y, Takenoshita S, Yoshimura K, Kudo K, Tachibana T, Nukiwa T, Hagiwara K. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med2007; 175(3): 263−268

[2]

Castellana G, Lamorgese V. Pulmonary alveolar microlithiasis. World cases and review of the literature. Respiration2003; 70(5): 549−555

[3]

Viswanathan R. Pulmonary alveolar microlithiasis. Thorax1962; 17(3): 251−256

[4]

Ucan ES, Keyf AI, Aydilek R, Yalcin Z, Sebit S, Kudu M, Ok U. Pulmonary alveolar microlithiasis: review of Turkish reports. Thorax1993; 48(2): 171−173

[5]

Mariotta S, Guidi L, Papale M, Ricci A, Bisetti A. Pulmonary alveolar microlithiasis: review of Italian reports. Eur J Epidemiol1997; 13(5): 587−590

[6]

Bhattacharjee BK, Barua R, Duta JK. Pulmonary alveolar microlithiasis. Indian J Chest Dis1965; 7: 51−53

[7]

Banerjea JC, Mukerji A, Maiti CR. Chronic cor pulmonale due to pulmonary alveolar microlithiasis. Indian Heart J1967; 19(1): 47−56

[8]

Rajagopalan CR, Krishna KVS, Rao M, Babu TN. Pulmonary alveolar microlithiasis. Report of a case. Indian J Pediatr1967; 34(236): 328−331

[9]

Rao CS, Rao YM, Reddy DB, Sarada D. Pulmonary alveolar microlithiasis. J Indian Med Assoc1968; 50(9): 427−428

[10]

Khattri HN, Sodhi JS, Gujeral JS, Dutta BN. Microlithiasis alveolaris pulmonale. J Assoc Physicians India1971; 19(4): 335−337

[11]

Thiruvengadam KV, Arunachalam K, Murali MR, Sarma AV, Varadarajan MG, Shetty BS, Swamidasan G. Pulmonary alveolar microlithiasis in a family. J Assoc Physicians India1972; 20(9): 707−712

[12]

Prabhakar BR, Sabharwal BD, Prabhakar H, Sethl RS. Pulmonary alveolar microlithiasis. A case report with review of literature. Indian J Pathol Bacteriol1974; 17(3): 193−196

[13]

Bhatia JL, Thind GS. Pulmonary alveolar microlithiasis. Ind J Tub1976; 23(3): 110−115

[14]

Mathur AS, Gupta DK, Garg RK. Pulmonary alveolar microlithiasis. Indian JRadiol1977; 31(3): 207−208

[15]

Thind GS, Bhatia JL. Pulmonary alveolar microlithiasis. Br J Dis Chest1978; 72(2): 151−154

[16]

Taneja VP, Sen D. Pulmonary alveolar microlithiasis (case report). J Assoc Physicians India1981; 29(5): 411−414

[17]

Gupta SK, Maini VK, Bedi RS. Pulmonary alveolar microlithiasis. Indian J Chest Dis Allied Sci1982; 24(1): 29−32

[18]

Saigal RK, Gupta K, Sandhu SK, Sidhu PK. Pulmonary alveolar microlithiasis. (A case report.)J Postgrad Med1982; 28(4): 235−237

[19]

Chetty A, Paul VK, Kumar A, Mitra DK, Chopra P. Alveolar microlithiasis—a case report with review of literature. Indian J Pediatr1983; 50(405): 453−455

[20]

Challa S, Dusaj IS, Kumar V, Mehrotra R. Pulmonary alveolar microlithiasis. Indian J Chest Dis Allied Sci1984; 26(4): 263−266

[21]

NatrajaIyer K. Sasikumar S, Devi SS. Pulmonary alveolar microlithiasis- a case report. Indian J Radiol1986; 40(1): 63−65

[22]

Bhadur P, Seetharaman ML, Krishnamurthy H. Pulmonary alveolar microlithiasis — a case report. Lung India1987; 5(4): 187−188

[23]

Pant K, Chawla R, Chhabra SK, Jain SK, Malik GB, Gaur SN. Pulmonary alveolar microlithiasis—a case report and review of literature. Indian J Chest Dis Allied Sci1988; 30(2): 141−147

[24]

Swarnkar JS, Wakodkar TD, Kirolikar SK, Diwakar RK. Pulmonary alveolar microlithiasis— a report of two cases. Lung India1989; 7(3): 140−142

[25]

Venkateswarlu J, Waghray P, Subbarao K, Kishore LT, Subbalakshmi M. pleural calcification in pulmonary alveolar microlithiasis − a case report. Lung India1989; 7(3): 143−145

[26]

Pant K, Shah A, Mathur RK, Chhabra SK, Jain SK. Pulmonary alveolar microlithiasis with pleural calcification and nephrolithiasis. Chest1990; 98(1): 245−246

[27]

Rao SD, Rekha S, Chandrasekhara MK, Shetty N, Srikrishna. Pulmonary alveolar microlithiasis in siblings. Indian Pediatr1991; 28(10): 1206−1210

[28]

Sharma SK, Sharma S, Mukhopadhyaya S, Padhy AK, Vijayraghavan M. Pulmonary alveolar microlithiasis–report of three cases with pulmonary function and exercise studies. Indian J Chest Dis Allied Sci1992; 34(4): 205−215

[29]

Babu MK, Kumar KR, Thomas JA. Pulmonary alveolar microlithiasis. Indian J Pathol Microbiol1992; 35(2): 149−152

[30]

Malhotra B, Kailan BM. Pulmonary alveolarmicrolithiasis–a case report. Ind J Tub1993; 40(1): 31−33

[31]

Malur PR, Ajay K, Jayaram N. Alveolar microlithiasis–report of two cases. Indian J Pathol Microbiol1993; 36(2): 163−167

[32]

Boghani A, Kumaresan K, Sundaram C, Bhaskar G. Pulmonary alveolar microlithiasis revisited with CT scan, bone scan and broncho-alveolar lavage. Lung India1993; 11(2): 37−39

[33]

Gaude GS, Pinto MJW, Bagga AS. Pneumothorax in pulmonary alveolar microlithiasis: a case report. Antiseptic1994; 91(4): 135−136

[34]

Singh NK, Gupta A. Pulmonary alveolar microlithiasis. J Assoc Physicians India1995; 43(9): 647−648

[35]

Kashyap S, Kumar M, Pal LS. Pulmonary alveolar microlithiasis in a Himachali woman. J Assoc Physicians India1996; 44(1): 56−57

[36]

Chatterji R, Gaude GS, Patil PV. Pulmonary alveolar microlithiasis: diagnosed by sputum examination and transbronchial biopsy. Indian J Chest Dis Allied Sci1997; 39(4): 263−267

[37]

Vidyasagar B, Ranjana SD, Jayan R, NagarajaSetty KL, Shivalingappa GS. Pulmonary alveolar microlithiasis. Lung India1998; 16(2): 80−82

[38]

Dwivedi MK, Pal RK, Borkar PB. Pulmonary alveolar microlithiasis. Indian J Radiol Imaging1999; 9(4): 195−196

[39]

Hira HS, Singh T, Chowdhary V. Pulmonary alveolar microlithiasis: role of transbronchial lung biopsy. J Assoc Physicians India2000; 48(8): 832−833

[40]

Gupta D, Aggarwal AN, Jindal SK. Lung static pressure- volume analysis can demonstrate alveolar involvement in pulmonary alveolar microlithiasis. Lung India2000; 18(2): 64−65

[41]

Shah MS, Nanavati KJ, Airon A, Shah RR, Joshi BD. Case report— pulmonary alveolar microlithiasis. Indian J Radiol Imaging2003; 13(3): 277−279

[42]

Bhalotra B, Gogia A, Gupta P, Jain N. A pulmonary snowstorm. Med J Aust2004; 180(9): 454

[43]

Patro SS, Kar CR. Pulmonary alveolar microlithiasis. Indian J Radiol Imaging2006; 16(4): 879−881

[44]

Unnithan J. Nandagopal. A rare case of pulmonary alveolar microlithiasis. Pulmon2006; 8(1): 27−29

[45]

Mitra S, Ghoshal AG. A family of pulmonary alveolar microlithiasis— a case report. Lung India2000; 18(3): 97−100

[46]

Hephzibah J, Oommen R, Mugesh B, Pradhip J. Pulmonary alveolar microlithiasis scinitigraphic features. Internet J Pulmonol Med2006; 9(1):12504

[47]

Thapa R, Ganguly D, Ghosh A. Pulmonary alveolar microlithiasis in siblings. Indian Pediatr2008; 45(2): 154−156

[48]

Chandra S, Mohan A, Guleria R, Das P, Sarkar C.Pulmonary alveolar microlithiasis. BMJ Case Rep2009; 2009: bcr09.2008.1012

[49]

Malhotra B, Sabharwal R, Singh M, Singh A. Pulmonary alveolar microlithiasis with calcified pleural plaques. Lung India2010; 27(4): 250−252

[50]

Gayathri Devi HJ, Mohan Rao KN, Prathima KM, Das JK. Pulmonary alveolar microlithiasis. Lung India2011; 28(2): 139−141

[51]

Shah M, Joshi JM. Bone scintigraphy in pulmonary alveolar microlithiasis. Indian J Chest Dis Allied Sci2011; 53(4): 221−223

[52]

Gayathri B, Keerthivasan S. Pulmonary alveolar microlithiasis. J Med2011; 12(1): 55−57

[53]

Sonwalkar P, Karthik M, Vishal NS, Praveen M, Patil MM. Pulmonary alveolar microlithiasis. JCDR2012; 6(7): 1296−1297

[54]

Galhotra R, Gupta K. Images–pulmonary alveolar microlithiasis (PAM). J Pulmon Resp Med2012; 2: 124

[55]

Flynn A, Agastyaraju AD. Pulmonary alveolar microlithiasis. Int J Case Rep Images2013; 4(2): 108−110

[56]

Sahoo MK, Karunanithi S, Bal CS. Pulmonary alveolar microlithiasis: imaging characteristics of planar and SPECT/CT bone scan versus 18F-FDG and 18F-sodium fluoride PET/CT scanning. Jpn J Radiol2013; 31(11): 766−769

[57]

Caffrey PR, Altman RS. Pulmonary alveolar microlithiasis occurring in premature twins. J Pediatr1965; 66(4): 758−763

[58]

Mariotta S, Ricci A, Papale M, De Clementi F, Sposato B, Guidi L, Mannino F. Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis2004; 21(3): 173−181

[59]

Castellana G, Gentile M, Castellana R, Fiorente P, Lamorgese V. Pulmonary alveolar microlithiasis: clinical features, evolution of the phenotype, and review of the literature. Am J Med Genet2002; 111(2): 220−224

[60]

Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet2006; 79(4): 650−656

[61]

Dogan OT, Ozsahin SL, Gul E, Arslan S, Koksal B, Berk S, Ozdemir O, Akkurt I. A frame-shift mutation in the SLC34A2 gene in three patients with pulmonary alveolar microlithiasis in an inbred family. Intern Med2010; 49(1): 45−49

[62]

Terada T. Pulmonary alveolar microlithiasis with cor pulmonale: an autopsy case demonstrating a marked decrease in pulmonary vascular beds. Respir Med2009; 103(11): 1768−1771

[63]

Chalmers AG, Wyatt J, Robinson PJ. Computed tomographic and pathological findings in pulmonary alveolar microlithiasis. Br J Radiol1986; 59(700): 408−411

[64]

Lauta VM. Pulmonary alveolar microlithiasis: an overview of clinical and pathological features together with possible therapies. Respir Med2003; 97(10): 1081−1085

[65]

Sears MR, Chang AR, Taylor AJ. Pulmonary alveolar microlithiasis. Thorax1971; 26(6): 704−711

[66]

Moran CA, Hochholzer L, Hasleton PS, Johnson FB, Koss MN. Pulmonary alveolar microlithiasis. A clinicopathologic and chemical analysis of seven cases. Arch Pathol Lab Med1997; 121(6): 607−611

[67]

Mascie-Taylor BH, Wardman AG, Madden CA, Page RL. A case of alveolar microlithiasis: observation over 22 years and recovery of material by lavage. Thorax1985; 40(12): 952−953

[68]

Kanat F, Teke T, Imecik O. Pulmonary alveolar microlithiasis with epididymal and periurethral calcifications causing obstructive azospermia. Int J Tuberc Lung Dis2004; 8(10): 1275

[69]

Arslan A, Yalin T, Akan H, Belet U. Pulmonary alveolar microlithiasis associated with calcifications in the seminal vesicles. J Belge Radiol1996; 79(3): 118−119

[70]

Coetzee T. Pulmonary alveolar microlithiasis with involvement of the sympathetic nervous system and gonads. Thorax1970; 25(5): 637−642

[71]

Yesner R, Skorneck AB. Pulmonary alveolar microlithiasis in mitral stenosis. Am J Pathol1956; 32(3): 611

[72]

Schmidt H, Lörcher U, Kitz R, Zielen S, Ahrens P, König R. Pulmonary alveolar microlithiasis in children. Pediatr Radiol1996; 26(1): 33−36

[73]

Ratjen FA, Schoenfeld B, Wiesemann HG. Pulmonary alveolar microlithiasis and lymphocytic interstitial pneumonitis in a ten year old girl. Eur Respir J1992; 5(10): 1283−1285

[74]

Portnoy LM, Amadeo B, Hennigar GR. Pulmonary alveolar microlithiasis: an unusual case (associated with milk alkali syndrome). Am J Clin Pathol1964; 41(2): 194−201

[75]

Ritchie DA, O’Connor SA, McGivern D. An unusual presentation of pulmonary alveolar microlithiasis and diaphyseal aclasia. Br J Radiol1992; 65(770): 178−181

[76]

Giallauria F, Giallauria G. Pulmonary alveolar microlithiasis. Thorax2011; 66(9): 840

[77]

Gasparetto EL, Tazoniero P, Escuissato DL, Marchiori E, Frare E Silva RL, Sakamoto D. Pulmonary alveolar microlithiasis presenting with crazy-paving pattern on high resolution CT. Br J Radiol2004; 77(923): 974−976

[78]

Marchiori E, Gonçalves CM, Escuissato DL, Teixeira KI, Rodrigues R, Barreto MM, Esteves M. Pulmonary alveolar microlithiasis: high-resolution computed tomography findings in 10 patients. J Bras Pneumol2007; 33(5): 552−557

[79]

Siddiqui NA, Fuhrman CR. Best cases from the AFIP: pulmonary alveolar microlithiasis. Radiographics2011; 31(2): 585−590

[80]

Sumikawa H, Johkoh T, Tomiyama N, Hamada S, Koyama M, Tsubamoto M, Murai S, Inoue A, Nakamura H, Tachibana T, Müller NL. Pulmonary alveolar microlithiasis: CT and pathologic findings in 10 patients. Monaldi Arch Chest Dis2005; 63(1): 59−64

[81]

Brown J, Leon W, Felton C. Hemodynamic and pulmonary studies in pulmonary alveolar microlithiasis. Am J Med1984; 77(1): 176−178

[82]

Dahabreh M, Najada A. Pulmonary alveolar microlithiasis in an 8-month-old infant. Ann Trop Paediatr2009; 29(1): 55−59

[83]

Yilmaz MI, Koc B, Kantarcioglu M, Akinci SB, Ayta H, Bulucu F, Bal S. Pulmonary alveolar microlithiasis after Varicella zoster infection in a patient presenting with antiphospholipid syndrome and discoid lupus. Rheumatol Int2002; 22(5): 213−215

[84]

Ozcelik U, Yalcin E, Arıyurek M, Ersoz DD, Cinel G, Gulhan B, Kiper N. Long-term results of disodium etidronate treatment in pulmonary alveolar microlithiasis. Pediatr Pulmonol2010; 45(5): 514−517

[85]

Jankovic S, Pavlov N, Ivkosic A, Erceg I, Glavina-Durdov M, Tocilj J, Dragisic-Ivulic S, Primorac D. Pulmonary alveolar microlithiasis in childhood: clinical and radiological follow-up. Pediatr Pulmonol2002; 34(5): 384−387

[86]

Shigemura N, Bermudez C, Hattler BG, Johnson B, Crespo M, Pilewski J, Toyoda Y. Lung transplantation for pulmonary alveolar microlithiasis. J Thorac Cardiovasc Surg2010; 139(3): e50−e52

[87]

Borrelli R, Fossi A, Volterrani L, Voltolini L. Right single-lung transplantation for pulmonary alveolar microlithiasis. Eur J Cardiothorac Surg2014; 45(2): e40

[88]

Edelman JD, Bavaria J, Kaiser LR, Litzky LA, Palevsky HI, Kotloff RM. Bilateral sequential lung transplantation for pulmonary alveolar microlithiasis. Chest1997; 112(4): 1140−1144

[89]

Samano MN, Waisberg DR, Canzian M, Campos SV, Pêgo-Fernandes PM, Jatene FB. Lung transplantation for pulmonary alveolar microlithiasis: a case report. Clinics (Sao Paulo)2010; 65(2): 233−236

[90]

Yin X, Wang H, Wu D, Zhao G, Shao J, Dai Y. SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures. Respir Med2013; 107(2): 217−222

[91]

Olauson H, Brandenburg V, Larsson TE. Mutation analysis and serum FGF23 level in a patient with pulmonary alveolar microlithiasis. Endocrine2010; 37(2): 244−248

[92]

Takahashi H, Chiba H, Shiratori M, Tachibana T, Abe S. Elevated serum surfactant protein A and D in pulmonary alveolar microlithiasis. Respirology2006; 11(3): 330−333

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag Berlin Heidelberg

AI Summary AI Mindmap
PDF (539KB)

1806

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/